UK Transparency Hub
← Back

NHS Framework Agreement - North of England - Tranche B

Awarded by NHS England · 2019-10-07T11:31:11+01:00 · £987,906,001

Description

NHS Framework for the NHS North of England Region, Branded Medicines - Tranche B, Cytokine Modulators and other monoclonal Antibodies, and Fondaparinux Offer reference number: CM/PHR/16/5527 CM/PHR/16/5527/01: NHS Framework for the NHS North Of England Region, Branded Medicines, Tranche B, 1 March 2020 to 28 February 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5527/02: NHS Framework for the NHS North Of England Region…

Buyer
NHS England
Value
£987,906,001
Category (CPV)
Pharmaceutical products
Award date
2019-10-07T11:31:11+01:00
Buyer constituency
runcorn-and-helsby

Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.

Loading…
Loading…